CRISAFULLI, Concetta
 Distribuzione geografica
Continente #
NA - Nord America 2.874
EU - Europa 2.580
AS - Asia 528
OC - Oceania 5
AF - Africa 1
SA - Sud America 1
Totale 5.989
Nazione #
US - Stati Uniti d'America 2.838
IE - Irlanda 719
SE - Svezia 666
CN - Cina 448
GB - Regno Unito 293
UA - Ucraina 273
DE - Germania 187
IT - Italia 184
FI - Finlandia 119
PL - Polonia 80
IN - India 67
CA - Canada 35
BE - Belgio 22
RU - Federazione Russa 15
FR - Francia 9
VN - Vietnam 6
AU - Australia 4
PT - Portogallo 3
HU - Ungheria 2
NL - Olanda 2
RO - Romania 2
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
ET - Etiopia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
MM - Myanmar 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 5.989
Città #
Dublin 719
Jacksonville 567
Chandler 556
Nyköping 359
Lancaster 246
Beijing 218
Dearborn 143
Princeton 137
Cambridge 119
Ashburn 113
Medford 111
Des Moines 106
Warsaw 80
Boardman 79
Messina 79
Ann Arbor 76
Hyderabad 44
Wilmington 41
Woodbridge 38
Jinan 32
Ottawa 32
Houston 26
Bremen 25
Shenyang 23
Brussels 22
Pune 20
Hebei 19
New York 19
Tianjin 18
Rome 15
Nanjing 14
Ningbo 14
Haikou 13
Hangzhou 12
Nanchang 12
San Mateo 11
Taizhou 11
Seattle 10
Zhengzhou 10
Guangzhou 9
Falls Church 8
Padova 8
Changsha 7
Dong Ket 6
Palermo 6
Auburn Hills 5
Catania 5
Cusano Milanino 5
Lanzhou 5
Pace 5
Fuzhou 4
Norwalk 4
Saint Petersburg 4
Taiyuan 4
Tappahannock 4
Washington 4
Biella 3
Chicago 3
Clearwater 3
Lisbon 3
Milan 3
Munich 3
Bergamo 2
Bitonto 2
Brescia 2
Cattolica 2
Cupertino 2
Edinburgh 2
Enna 2
Fort Worth 2
Hefei 2
Helsinki 2
Jiaxing 2
Kunming 2
Los Angeles 2
Modica 2
Naples 2
Novokuznetsk 2
Puxian 2
Salerno 2
Ada 1
Ardabil 1
Atlanta 1
Auckland 1
Augusta 1
Bagheria 1
Bengaluru 1
Birmingham 1
Bishkek 1
Boston 1
Brisbane 1
Brossard 1
Budapest 1
Chengdu 1
Dorgali 1
Duncan 1
Florence 1
Foggia 1
Frankfurt am Main 1
Hanover 1
Totale 4.356
Nome #
CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study. 104
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 94
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 88
CCR5Δ32 Polymorphism Associated with a Slower Rate DiseaseProgression in a Cohort of RR-MS Sicilian Patients 81
PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway. 70
Olprinone attenuates the development of ischemia/reperfusion injury of the gut 69
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 68
Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study 66
FMO3 allelic variants in a Mediterranean population frequency and linkage analysis. 65
A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment. 63
Protective effect of hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome. 61
null 60
Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients. 59
Molecular analysis of CCM genes promoter regions 59
null 59
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 59
CNVs inform the biological network of Autism spectrum disorder 57
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 56
Green Tea polyphenol extract attenuates zymosan-induced non-septic shock in mice 55
CASE-CONTROL ASSOCIATION STUDY FOR 10 GENES IN PATIENTS WITH SCHIZOPHRENIA: INFLUENCE OF 5HTR1A VARIATION rs10042486 ON SCHIZOPHRENIA AND RESPONSE TO ANTIPSYCHOTICS. 54
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy 53
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 53
Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats 53
Enrichment pathway analysis. The inflammatory genetic background in bipolar disorder 53
The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants 53
Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma 52
Melatonin modulates signal transduction pathways and apoptosis in experimental colitis 52
Glycogen synthase kinase-3 beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut 51
Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma 51
CASE-CONTROL ASSOCIATION STUDY OF GRIA1, GRIA2 AND GRIA4 POLYMORPHISMS IN BIPOLAR DISORDER. 51
Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia 51
Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma 50
SOLUBLE GITR (GLUCOCORTICOID- INDUCED TNFR- RELATED GENE) FUSION PROTEIN INHIBITS ACUTE LUNG INFLAMMATION. 50
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 50
Immunomodulatory effects of etanercept in an experimental model of spinal cord injury 49
TNF-ALPHA INHIBITION PREVENTS EARLY TIGHT JUNCTION REARRANGEMENT AND APOPTOSIS OF ILEAL ENTEROCYTES IN EXPERIMENTAL COLITIS. 49
TNF-alpha inhibition prevents early tight junction rearrangement and apoptosis of ileal enterocytes in experimental colitis. 49
Effects of verbascoside, biotechnologically purified by Syringa vulgaris plant cell cultures, in a rodent model of periodontitis 49
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept 49
Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, amelioratesintestinal damage in rat models of colitis and shock 49
Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells 48
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 48
A genetic dissection of antipsychotic induced movement disorders 48
Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice 47
Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice 47
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord 47
Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. 47
Genetic variants associated with psychotic symptoms across psychiatric disorders 47
N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury 46
Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein 46
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 46
Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model. 46
null 46
Increased oxidative-related mechanisms in the spinal cord injury in old rats 45
Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. 45
CCR5Δ32 POLYMORPHISM ASSOCIATED WITH A SLOWER RATE DISEASE PROGRESSION IN A COHORT OF RR-MS SICILIAN PATIENTS 45
Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder 45
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON SEPTICK SHOCK IN MICE 45
CASE-CONTROL ASSOCIATION STUDY OF 14 VARIANTS OF CREB1, CREBBP AND CREM ON DIAGNOSIS AND TREATMENT OUTCOME IN MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER. 44
Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice 44
Effects of Hypericum perforatum extract in a rat model of ischemia and reperfusion injury 43
Pyrrolidine dithiocarbamate reduced experimental periodontitis 43
Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation 43
Neuronal cell adhesion genes and antidepressant response in three independent samples 43
Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation 42
Role of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice 42
Estrogen Receptor-{alpha} as a Drug Target Candidate for Preventing Lung Inflammation. 42
Effects of genetic and pharmacological inhibition of TNF-alpha in the regulation of inflammation in macrophages. 42
Neuroprotection and enhanced recovery with Hypericum perforatum extract after experimental spinal cord injury in mice 41
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury 41
Inhibition of glycogen synthase kinase-3 beta attenuates the development of carrageenan-induced lung injury in mice 41
Molecular Pathways within Autism Spectrum Disorder Endophenotypes 41
Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. 40
Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats 40
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 40
Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. 39
Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis 39
COMT AND AGE AT ONSET IN MOOD DISORDERS: A REPLICATION AND EXTENSION STUDY. 39
THE ROLE ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR-alpha) IN THE REGULATION OF INFLAMMATION IN MACROPHAGES. 38
null 38
NOVEL PDCD10 PROMOTER VARIANTS IN PATIENTS WITH CEREBRAL CAVERNOUSMALFORMATIONS 38
ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders 38
MECHANISM OF THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOID : RELATIONSHIP WITH THE PPAR- α LIGAND PATHWAY 37
null 37
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. 37
FAILURE TO REPLICATE INFLUENCE OF GRIK4 AND GNB3 POLYMORPHISMS ON TREATMENT OUTCOME IN MAJOR DEPRESSION. 36
Genetic Insights from a Molecular Pathway Analysis on Two Independent Samples of Autistic Patients 36
Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma. 35
Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice 34
THE GENETICS OF ANTIPSYCHOTIC INDUCED TREMORS: A GENOME-WIDE ANALYSIS ON THE STEP-BD SCP SAMPLE. 34
Progress and prospects in pharmacogenetics of antidepressant drugs 34
Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease (Molecular Biology Reports, (2020), 47, 1, (191-200), 10.1007/s11033-019-05119-5) 34
The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation 33
Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma 33
null 33
The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. 33
INFLUENCE OF GRIA1, GRIA2 AND GRIA4 POLYMORPHISMS ON DIAGNOSIS AND RESPONSE TO ANTIPSYCHOTIC TREATMENT IN PATIENTS WITH SCHIZOPHRENIA. 33
The biological pathways of Alzheimer disease: a review 33
null 32
null 32
Totale 4.795
Categoria #
all - tutte 23.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 6 7
2019/20201.051 149 67 3 67 6 138 137 111 23 164 167 19
2020/2021887 105 13 183 36 61 93 31 71 97 121 41 35
2021/2022841 4 88 24 10 22 12 48 36 13 152 155 277
2022/20232.168 170 158 94 187 192 222 10 140 897 17 55 26
2023/2024439 42 85 30 46 49 86 11 27 7 56 0 0
Totale 6.249